Information Provided By:
Fly News Breaks for March 4, 2020
CDLX
Mar 4, 2020 | 09:45 EDT
SunTrust analyst Youssef Squali raised the firm's price target on Cardlytics to $77 from $52 and keeps a Buy rating on the shares. The analyst notes the company's "strong" Q4 results while attributing the soft Q1 guidance to the impact of coronavirus and the slower WF monetization ramp. Squali adds that a growing sales team and greater advertiser density should allow Cardlytics to sustain monetization/revenue growth at 20%-30% "for years to come" and attributes the sharp post-earnings sell-off to the 400% trailing-12-month run-up in the stock relative to the 7.5% advance for S&P500.
News For CDLX From the Last 2 Days
CDLX
Apr 15, 2021 | 06:45 EDT
Wells Fargo analyst Timothy Willi upgraded Cardlytics to Overweight from Equal Weight with a $150 price target. Willi believes the recent underperformance has created a favorable entry point for shares, and sees several fundamental catalysts over the near to medium term, the analyst tells investors in a research note. The analyst views the risk/reward as favorable at current levels and the liquidity position as stable.